Germany's cannabis law faces backlash as report exposes rising THC risks

A new report has sharply criticised Germany's Cannabis Consumption Act, raising concerns over its impact since implementation. The second interim findings from the Ekocan research project highlight surging THC levels and a collapse in early intervention programmes. Government officials are now preparing to discuss the law's future.

The report's release has sparked strong reactions from senior ministers. Federal Health Minister Nina Warken (CDU) called the partial legalisation of recreational cannabis a 'mistake'. Family Minister Karin Prien (CDU) accused the previous traffic-light coalition of undermining addiction prevention for young people. Interior Minister Alexander Dobrindt (CSU) went further, labelling the law a 'total fiasco'.

Medical cannabis imports have soared since 2023, increasing more than sixfold. At the same time, the report notes that the boundaries between medical and recreational use have become unclear. A ministry spokesperson confirmed that early intervention initiatives have seen a steep decline under the current regulations. The Federal Health Ministry will now hold internal government talks to assess the next steps. A spokesperson described the report's conclusions as unambiguous, signalling a likely review of the existing framework.

The Ekocan findings point to rising THC potency and weakened prevention efforts since the law took effect. With cross-party criticism mounting, the government must now decide whether to amend or repeal the legislation. Official discussions are expected to begin shortly.